|
|
December 09, 2007: CME talk for doctors: Chennai."Experiences with Insulin pumps
in India" |
Jothydev Kesavadev spoke at the first Medtronic diabetes update for doctors
at Chennai on his experiences using Insulin Pumps in both Type 1 and in more
than 60 type 2 diabetes patients.
Dr.Scott Lee (USA), Dr.Tadej Battelino(Slovania), Dr.V.Mohan(chennai),
Mrs.Shilpa Joshi(Mumbai), Dr.Usha Sriram(Chicago), Dr.Chandalia(Mumbai),
Dr.A Sharada(Bangalore), Dr.Sunil M Jain(Indore) Dr.Thomas Sweeney(USA),
Ms.Sonal Modi(Mumbai) were the other speakers.
|
|
One selected question:
Prof.Dr.Chandalia(Mumbai): What is the average A1c values of your type 1
diabetes patients on pumps?
Ans by Jothydev: Sir, I do admit that it is difficult to bring A1c below
7.5% in young type 1 patients.
However more than 54 of our type 2 diabetes patients treated with insulin
pumps at Jothydev's diabetes center in Trivandrum
are maintaining A1c below 5.8% thanks to our tele follow up program.From the
bitter lessons we have learnt out of a few of our out station patients
we have stopped deploying pumps to those very affordable, affluent patients
who do not follow up with us after pump deployment and fly back to their
home country not answering to our e mails or tele follow up calls.
It is quite important to notice that irrespective of type or stage of
diabetes all patients reported tremendous improvement in quality of life
after pump.
No patient had pump occlusions contrary to some other reports from
elsewhere and the probable reason could be the use of only aspart
insulin(Novorapid) in our patients.
In the picture is seen Dr.Tadej Battelino having dinner with Medtronic India
team, Paul Amirtharaj(Medtronic country head), Vishnu, etc, and Jothydev at
Hotel Accord Metropoliton, Chennai |
|
|
|
|
|